Reflux oesophagitis: Preventive eradication of Helicobacter pylori necessary in patients given omeprazol?;Reflux-oesofagitis: Preventieve eradicatie van Helicobacter pylori nodig bij patienten die omeprazol krijgen?

Nederlands Tijdschrift voor Geneeskunde

Volumn 142, Issue 16, 1998, Pages 883-885

  Kuipers, E J ^a   Klinkenberg Knol, E C ^a   Festen, H P M ^a   Meuwissen, S G M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE;

ARTICLE; GASTRITIS; HELICOBACTER PYLORI; HUMAN; REFLUX ESOPHAGITIS; STOMACH ACID SECRETION;

ENZYME INHIBITORS; ESOPHAGITIS, PEPTIC; FEMALE; GASTRITIS, ATROPHIC; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROSPECTIVE STUDIES;

EID: 0032542968     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Klinkenberg-Knol EC, Festen HPM, Jansen JBMJ, Lamers CB, Nelis F, Snel P, et al. Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Ann Intern Med 1994;121:161-7.
2. Kuipers EJ, Peña AS, Meuwissen SGM. Helicobacter pylori-infectie oorzakelijke factor bij ontstaan carcinoom en lymfoom van de maag; verslag WHO-consensusbespreking. Ned Tijdschr Geneeskd 1995;139:709-12.
3. Kuipers EJ, Uyterlinde AM, Peña AS, Hazenberg HJ, Bloemena E, Lindeman J, et al. Increase of Helicobacter pylon-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol 1995;90:1401-6.
4. Meining A, Bosseckert H, Caspary WF, Nauert C, Stolte M. H2-receptor antagonists and antacids have an aggravating effect on Helicobacter pylori gastritis in duodenal ulcer patients. Aliment Pharmacol Ther 1997;11:729-34.
5. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, Havu N, Festen HP, Liedman B, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996;334:1018-22.
6. Kuipers EJ, Uyterlinde AM, Peña AS, Roosendaal R, Pals G, Nelis GF, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995;345:1525-8.
7. Sachs G. Gastritis, Helicobacter pylon, and proton pump inhibitors. Gastroenterology 1997;112:1033-6.
8. Kuipers EJ, Klinkenberg-Knol EC, Festen HPM, Meuwissen SGM. Lansoprazole, H. pylori, and atrophic gastritis [letter]. Gastroenterology 1997;113:2018-9.
9. Eissele R, Brunner G, Simon B, Solcia E, Arnold R. Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia. Gastroenterology 1997;112:707-17.
10. Lundell L, Havu N, Andersson A, Miettinen P, Myrvold HE, Pedersen SA, et al. Gastritis development and acid suppression therapy revisited. Results of a randomized clinical study with long-term follow-up. Gastroenterology 1997;112:A771.
11. Hansson LE, Nyrén O, Hsing AW, Bergstrom R, Josefsson S, Chow WH, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996;335:242-9.
12. Schenk BE, Kuipers EJ, Nelis GF, Thijs JC, Bloemena E, Snel P, et al. H. pylori eradication for chronic gastritis during omeprazole therapy for GERD [abstract]. Gastroenterology [ter perse].